CT | AI | Visual/AI | Visual | |
---|---|---|---|---|
Age (median and range) | 48 (18–83) | |||
Sex | ||||
Male | 81 (54%) | |||
Female | 69 (46%) | |||
Nodule size (median and range) | 10 (5–89) | |||
Per Case (CXR) classification | ||||
Positive | 99/150 (66%) | 92/150 (61.3%) | 93/150 (62%) | 92/150 (61.3%) |
Number of nodules | ||||
1 nodule | 62/99 (62.6%) | 57/92 (62%) | 61/93 (65.6%) | 62/92 (67.4%) |
2 nodules | 12/99 (12.1%) | 12/92 (13%) | 9/93 (9.7%) | 9/92 (9.8%) |
3 nodules | 4/99 (4%) | 5/92 (5.4%) | 8/93 (8.6%) | 9/92 (9.8%) |
4 nodules | 3/99 (3%) | 6/92 (6.5%) | 4/93 (4.3%) | 4/92 (4.3%) |
5 nodules | 2/99 (2%) | 4/92 (4.3%) | 4/93 (4.3%) | 1/92 (1.1%) |
6 nodules | 16/99 (16.3%) | 8/92 (8.7%) | 7/93 (7.5%) | 7/92 (7.6%) |
CXR nodule laterality | ||||
Right lung lobe | 41/99 (41.4%) | 42/92 (45.7%) | 40/93 (43%) | 39/92 (42.4%) |
Left lung lobe | 36/99 (36.4%) | 30/92 (32.6%) | 33/93 (35.5%) | 34/92 (37%) |
Bilateral lung lobes | 22/99 (22.2%) | 20/92 (21.7%) | 20/93 (21.5%) | 19/92 (20.6%) |
Number of the nodule | 216 | 188 | 181 | 170 |
Nodule texture | ||||
Solid | 139/216 (64.4%) | |||
GG | 68/216 (31.5%) | |||
Cystic lesion | 9/216 (4.1%) |